Emerson to Present at Barclays 43rd Annual Industrial Select Conference
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 5 days ago
0mins
Should l Buy EMR?
Source: PRnewswire
- Executive Attendance: Emerson's President and CEO Lal Karsanbhai, along with CFO Mike Baughman, will present at the Barclays 43rd Annual Industrial Select Conference on February 17, 2026, showcasing the company's leadership in automation.
- Schedule Details: The presentation is set to begin at 10:25 a.m. Eastern Time (9:25 a.m. Central Time), expected to attract attention from investors and industry experts, thereby enhancing Emerson's market visibility.
- Webcast and Archiving: The presentation will be webcast live on Emerson's website and archived for later access, ensuring that investors who cannot attend in real-time can still obtain relevant information, thus improving communication with stakeholders.
- Investor Relations Focus: Emerson emphasizes the importance of disclosing material information through its Investor Relations website, ensuring investors are kept informed about company developments, reflecting the company's commitment to transparency and compliance.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy EMR?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on EMR
Wall Street analysts forecast EMR stock price to rise
14 Analyst Rating
7 Buy
6 Hold
1 Sell
Moderate Buy
Current: 144.980
Low
125.00
Averages
150.46
High
170.00
Current: 144.980
Low
125.00
Averages
150.46
High
170.00
About EMR
Emerson Electric Co. is a global technology and software company that provides solutions for customers in a wide range of end markets around the world. The Company operates through seven segments under two business groups, such as Intelligent Devices and Software and Control. Its Intelligent Devices business includes Final Control, Measurement & Analytical, Discrete Automation, and Safety & Productivity. Software and Control business includes Control Systems & Software, Test & Measurement, and AspenTech. Its Final Control segment is a global provider of control valves, isolation valves, shutoff valves, pressure relief valves, pressure safety valves, actuators, and regulators for process and hybrid industries. Its Measurement & Analytical segment is a supplier of intelligent instrumentation measuring the physical properties of liquids or gases. AspenTech segment provides asset optimization software that enables industrial manufacturers to design, operate and maintain their operations.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Emerson to Present at Barclays 43rd Annual Industrial Select Conference
- Executive Attendance: Emerson's President and CEO Lal Karsanbhai, along with CFO Mike Baughman, will present at the Barclays 43rd Annual Industrial Select Conference on February 17, 2026, showcasing the company's leadership in automation.
- Schedule Details: The presentation is set to begin at 10:25 a.m. Eastern Time (9:25 a.m. Central Time), expected to attract attention from investors and industry experts, thereby enhancing Emerson's market visibility.
- Webcast and Archiving: The presentation will be webcast live on Emerson's website and archived for later access, ensuring that investors who cannot attend in real-time can still obtain relevant information, thus improving communication with stakeholders.
- Investor Relations Focus: Emerson emphasizes the importance of disclosing material information through its Investor Relations website, ensuring investors are kept informed about company developments, reflecting the company's commitment to transparency and compliance.
See More
Wall Street Analysts Adjust Ratings
- Analyst Rating Changes: Top Wall Street analysts have adjusted their ratings on several companies, including upgrades, downgrades, and initiations, reflecting varying market perspectives on these stocks.
- Market Focus: Analysts' views on SNAP stock have garnered investor attention, and while specific ratings are not detailed in the report, there remains a divergence in market expectations for its future performance.
- Impact of Rating Changes: The changes in ratings could influence investor decisions, especially in the current market environment where reliance on analyst opinions is heightened, potentially leading to stock price volatility.
- Further Information: For a complete view of all analyst rating changes, including upgrades, downgrades, and initiations, it is recommended to visit Benzinga's analyst ratings page for more comprehensive information and data.
See More
Wall Street Analysts Adjust Ratings
- Analyst Rating Updates: Top Wall Street analysts have adjusted their ratings on several companies, reflecting the latest market sentiment towards these stocks, although specific names were not disclosed, investors should pay attention to these changes for informed decision-making.
- Impact of Rating Changes: Upgrades or downgrades in ratings can directly influence the market performance of the related stocks, prompting investors to closely monitor these shifts to timely adjust their portfolios for optimized returns.
- Market Reaction Expectations: Analyst rating adjustments often trigger immediate market reactions, particularly when investors have a high level of interest in specific stocks, potentially leading to short-term price volatility.
- Information Access Channels: Investors can visit the analyst ratings page to obtain a comprehensive view of rating changes, including upgrades, downgrades, and new initiations, thereby better grasping market dynamics.
See More
Biotech ETF Recommended, Amcor Reports Strong Earnings
- Biotech Investment Recommendation: Jason Snipe, founder of Odyssey Capital Advisors, recommended the iShares Biotechnology ETF (NYSE:IBB) on CNBC, emphasizing the potential for long-term investment in the biotech sector, reflecting confidence in future growth.
- Amcor's Strong Earnings: Amcor plc (NYSE:AMCR) reported second-quarter earnings of $0.86 per share on February 3, beating the analyst consensus of $0.85, although quarterly sales of $5.449 billion fell short of the $5.576 billion estimate, indicating strong profitability.
- Positive Stock Performance: Following the earnings report, Amcor's stock rose by 8.1% to close at $48.56, suggesting a favorable market reaction to its financial performance, which may attract more investor interest.
- Emerson Electric's Better-Than-Expected Results: Emerson Electric Co. (NYSE:EMR) reported first-quarter adjusted EPS of $1.46, exceeding the $1.41 consensus estimate, and raised its FY26 EPS guidance, showcasing ongoing growth potential in the industrial sector.
See More
Wall Street Analysts Adjust Ratings
- Analyst Rating Updates: Top Wall Street analysts have adjusted their ratings on several companies, indicating a shift in market sentiment that could influence investor decisions and market trends.
- Upgrades and Downgrades: The rating changes include both upgrades and downgrades for certain stocks, prompting investors to pay attention to these shifts to assess potential investment opportunities and risks.
- Market Reaction Expectations: Analyst rating adjustments typically trigger immediate market reactions, and investors should closely monitor how these changes impact stock prices to timely adjust their investment strategies.
- Comprehensive Rating View: For a complete overview of all analyst rating changes, including upgrades, downgrades, and initiations, it is recommended to visit the analyst ratings page for detailed data and analysis.
See More
Wall Street Volatility Highlights Importance of Portfolio Diversification
- Tech Stock Decline: Tech stocks have been severely impacted by recent volatility, with AMD's share price plummeting 17% as investor confidence in the enterprise software sector wanes, highlighting the risks of over-reliance on tech investments.
- Strong Performance of Blue-Chip Stocks: In stark contrast to tech stocks, the Dow Jones Industrial Average rose by 260 points, or 0.5%, indicating that old-economy companies are demonstrating greater resilience during market turmoil, attracting investors seeking stability.
- Winners Across Industries: Companies like Campbell, PepsiCo, Smuckers, and Kraft Heinz have seen their stock prices rise despite the threat of GLP-1, reflecting ongoing consumer demand and confidence in the food sector amidst market fluctuations.
- Recovery in Banks and Industrials: Recent gains in bank stocks and industrials such as Honeywell, Dover, and Emerson Electric suggest that investors believe these firms will benefit from efficiency improvements brought by artificial intelligence, enhancing their investment appeal.
See More
Emerson to Present at Barclays 43rd Annual Industrial Select Conference
- Executive Attendance: Emerson's President and CEO Lal Karsanbhai, along with CFO Mike Baughman, will present at the Barclays 43rd Annual Industrial Select Conference on February 17, 2026, showcasing the company's leadership in automation.
- Schedule Details: The presentation is set to begin at 10:25 a.m. Eastern Time (9:25 a.m. Central Time), expected to attract attention from investors and industry experts, thereby enhancing Emerson's market visibility.
- Webcast and Archiving: The presentation will be webcast live on Emerson's website and archived for later access, ensuring that investors who cannot attend in real-time can still obtain relevant information, thus improving communication with stakeholders.
- Investor Relations Focus: Emerson emphasizes the importance of disclosing material information through its Investor Relations website, ensuring investors are kept informed about company developments, reflecting the company's commitment to transparency and compliance.
See More
Wall Street Analysts Adjust Ratings
- Analyst Rating Changes: Top Wall Street analysts have adjusted their ratings on several companies, including upgrades, downgrades, and initiations, reflecting varying market perspectives on these stocks.
- Market Focus: Analysts' views on SNAP stock have garnered investor attention, and while specific ratings are not detailed in the report, there remains a divergence in market expectations for its future performance.
- Impact of Rating Changes: The changes in ratings could influence investor decisions, especially in the current market environment where reliance on analyst opinions is heightened, potentially leading to stock price volatility.
- Further Information: For a complete view of all analyst rating changes, including upgrades, downgrades, and initiations, it is recommended to visit Benzinga's analyst ratings page for more comprehensive information and data.
See More
Wall Street Analysts Adjust Ratings
- Analyst Rating Updates: Top Wall Street analysts have adjusted their ratings on several companies, reflecting the latest market sentiment towards these stocks, although specific names were not disclosed, investors should pay attention to these changes for informed decision-making.
- Impact of Rating Changes: Upgrades or downgrades in ratings can directly influence the market performance of the related stocks, prompting investors to closely monitor these shifts to timely adjust their portfolios for optimized returns.
- Market Reaction Expectations: Analyst rating adjustments often trigger immediate market reactions, particularly when investors have a high level of interest in specific stocks, potentially leading to short-term price volatility.
- Information Access Channels: Investors can visit the analyst ratings page to obtain a comprehensive view of rating changes, including upgrades, downgrades, and new initiations, thereby better grasping market dynamics.
See More
Biotech ETF Recommended, Amcor Reports Strong Earnings
- Biotech Investment Recommendation: Jason Snipe, founder of Odyssey Capital Advisors, recommended the iShares Biotechnology ETF (NYSE:IBB) on CNBC, emphasizing the potential for long-term investment in the biotech sector, reflecting confidence in future growth.
- Amcor's Strong Earnings: Amcor plc (NYSE:AMCR) reported second-quarter earnings of $0.86 per share on February 3, beating the analyst consensus of $0.85, although quarterly sales of $5.449 billion fell short of the $5.576 billion estimate, indicating strong profitability.
- Positive Stock Performance: Following the earnings report, Amcor's stock rose by 8.1% to close at $48.56, suggesting a favorable market reaction to its financial performance, which may attract more investor interest.
- Emerson Electric's Better-Than-Expected Results: Emerson Electric Co. (NYSE:EMR) reported first-quarter adjusted EPS of $1.46, exceeding the $1.41 consensus estimate, and raised its FY26 EPS guidance, showcasing ongoing growth potential in the industrial sector.
See More
Wall Street Analysts Adjust Ratings
- Analyst Rating Updates: Top Wall Street analysts have adjusted their ratings on several companies, indicating a shift in market sentiment that could influence investor decisions and market trends.
- Upgrades and Downgrades: The rating changes include both upgrades and downgrades for certain stocks, prompting investors to pay attention to these shifts to assess potential investment opportunities and risks.
- Market Reaction Expectations: Analyst rating adjustments typically trigger immediate market reactions, and investors should closely monitor how these changes impact stock prices to timely adjust their investment strategies.
- Comprehensive Rating View: For a complete overview of all analyst rating changes, including upgrades, downgrades, and initiations, it is recommended to visit the analyst ratings page for detailed data and analysis.
See More
Wall Street Volatility Highlights Importance of Portfolio Diversification
- Tech Stock Decline: Tech stocks have been severely impacted by recent volatility, with AMD's share price plummeting 17% as investor confidence in the enterprise software sector wanes, highlighting the risks of over-reliance on tech investments.
- Strong Performance of Blue-Chip Stocks: In stark contrast to tech stocks, the Dow Jones Industrial Average rose by 260 points, or 0.5%, indicating that old-economy companies are demonstrating greater resilience during market turmoil, attracting investors seeking stability.
- Winners Across Industries: Companies like Campbell, PepsiCo, Smuckers, and Kraft Heinz have seen their stock prices rise despite the threat of GLP-1, reflecting ongoing consumer demand and confidence in the food sector amidst market fluctuations.
- Recovery in Banks and Industrials: Recent gains in bank stocks and industrials such as Honeywell, Dover, and Emerson Electric suggest that investors believe these firms will benefit from efficiency improvements brought by artificial intelligence, enhancing their investment appeal.
See More
